Correct Answer: A. Prostate carcinoma
Prostate carcinoma is the classic example of a malignancy that produces osteoblastic (sclerotic) bone metastases. This occurs because prostate cancer cells secrete osteoblast-stimulating factors, particularly bone morphogenetic proteins (BMPs) and other growth factors, which directly activate osteoblasts to lay down new bone matrix. Unlike most other cancers that cause osteolytic (bone-destroying) metastases through osteoclast activation, prostate cancer triggers excessive osteoid and bone formation, creating the characteristic "ivory-like" or "sclerotic" appearance on X-ray. This osteoblastic response is so characteristic that when you see predominantly sclerotic bone metastases on imaging in an Indian male patient, prostate cancer should be the first differential diagnosis. The mechanism involves androgen-responsive prostate cancer cells producing factors like TGF-β and FGF that promote osteoblast proliferation and differentiation. This is a high-yield discriminator in pathology exams because most other solid organ cancers (breast, lung, kidney, thyroid) produce osteolytic lesions instead. The sclerotic nature makes these metastases appear denser than normal bone, and they are often multiple and widespread, particularly affecting the axial skeleton (spine, pelvis, ribs).
Why the other options are wrong
B. Breast carcinoma — Breast cancer typically produces osteolytic (lytic) bone metastases, not osteoblastic ones. While breast cancer is the most common cause of bone metastases in Indian women, it causes bone destruction through osteoclast activation via RANKL signaling, creating punched-out lucent lesions on X-ray. Some breast cancers may show mixed lytic-sclerotic patterns, but predominantly osteoblastic metastases are not characteristic of breast carcinoma. C. Stomach carcinoma — Gastric cancer, a leading malignancy in India, typically metastasizes to liver, peritoneum, and distant lymph nodes rather than bone. When gastric cancer does involve bone, it produces osteolytic lesions through inflammatory cytokine release (IL-6, TNF-α), not osteoblastic stimulation. Sclerotic bone metastases are exceptionally rare in gastric carcinoma and would not be a characteristic feature. D. Bone Carcinoma — This option is nonsensical in the context of bone metastases—primary bone carcinomas (osteosarcoma, Ewing's sarcoma) are not 'secondaries' (metastases). The question specifically asks about secondary bone lesions (metastases from distant primary tumors). Additionally, primary bone malignancies produce their own bone destruction/formation patterns unrelated to the osteoblastic response seen in prostate cancer metastases.
High-Yield Facts
- Prostate cancer is the ONLY common solid organ malignancy that characteristically produces osteoblastic (sclerotic) bone metastases.
- Osteoblastic metastases appear as areas of increased bone density ('ivory-like' or 'sclerotic') on X-ray, caused by osteoblast-stimulating factors (BMP, TGF-β, FGF) secreted by prostate cancer cells.
- Breast, lung, kidney, thyroid cancers produce osteolytic metastases (bone destruction) via RANKL-mediated osteoclast activation, not osteoblastic response.
- Axial skeleton involvement (spine, pelvis, ribs) is most common in prostate cancer bone metastases; sclerotic lesions are often multifocal and widespread.
- PSA elevation + sclerotic bone metastases on imaging in an Indian male is pathognomonic for metastatic prostate cancer; this combination is a high-yield exam pattern.
Mnemonics
SCLEROTIC BONE METASTASES = PROSTATE When you see sclerotic (dense, ivory-like) bone lesions on imaging → think PROSTATE first. All other common cancers cause lytic (lucent, punched-out) lesions. Use this as your reflex: Sclerotic = Prostate. LYTIC vs OSTEOBLASTIC LYTIC (bone destruction): Breast, Lung, Kidney, Thyroid, Myeloma. OSTEOBLASTIC (bone formation): Prostate. The 'P' stands alone—it's the exception that proves the rule.
NBE Trap
NBE often pairs "bone metastases" with "breast cancer" because breast cancer is the most common cause of bone metastases overall in Indian women; students may confuse frequency with the type of lesion produced. The trap is that while breast cancer causes bone metastases, they are osteolytic, not osteoblastic—a critical distinction that separates prostate from all other common malignancies.
Clinical Pearl
In Indian clinical practice, an elderly male presenting with back pain, elevated PSA, and sclerotic lesions on spine X-ray is metastatic prostate cancer until proven otherwise. The osteoblastic response is so characteristic that it is used as a diagnostic clue—unlike the lytic lesions of breast cancer or myeloma, which would present differently. This distinction directly impacts staging, prognosis, and hormone therapy decisions.
_Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 20 (Neoplasia); Harrison's Principles of Internal Medicine, Ch. 97 (Prostate Cancer)_